Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
about
Novel avenues for drug discovery in diabetic kidney disease.Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.Renal Outcomes of Antidiabetic Treatment Options for Type 2 Diabetes-A Proposed MARE Definition
P2860
Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Improved clinical trial enroll ...... sk of end-stage renal disease.
@en
type
label
Improved clinical trial enroll ...... sk of end-stage renal disease.
@en
prefLabel
Improved clinical trial enroll ...... sk of end-stage renal disease.
@en
P2093
P2860
P1433
P1476
Improved clinical trial enroll ...... sk of end-stage renal disease.
@en
P2093
Adam M Smiles
Andrzej S Krolewski
Andrzej T Galecki
James H Warram
Jan Skupien
Joseph V Bonventre
Kevin L Duffin
Matthew D Breyer
Monika A Niewczas
Nick Pullen
P2860
P304
P356
10.1016/J.KINT.2017.02.010
P407
P577
2017-04-07T00:00:00Z